The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Neurotrope, Inc. Shareholders & a Lead Plaintiff De...
June 06 2017 - 11:51AM
Business Wire
The Klein Law Firm announces that a class action complaint has
been filed on behalf of shareholders of Neurotrope, Inc. (NASDAQ:
NTRP) who purchased shares between January 7,
2016, and April 28, 2017. The action, which was filed in the
U.S. District Court for the Southern District of New York, alleges
that the Company violated federal securities laws.
The complaint alleges that throughout the Class Period
Neurotrope issued materially false and misleading statements and/or
failed to disclose material information concerning the efficacy of
its lead product candidate, Bryostatin-1. On May 1, 2017,
Neurotrope issued a press release announcing “positive top-line
results” of the pivotal Phase 2b trials of Bryostatin-1, noting
“improvement in patients with moderate to severe Alzheimer’s
disease.” However, the underlying trial data contradicts these
representations, as the top-line data relating to the 20 microgram
dose of Bryostatin-1 failed to produce results that were
statistically significant. In addition, Neurotrope failed to
disclose statements regarding the efficacy of the 40 microgram dose
with regard to its primary and secondary endpoints. Upon this news,
shares of Neurotrope fell from a close of $18.81 on April 28, 2017,
to a close of $6.97 per share on May 1, 2017.
Shareholders have until July 17, 2017 to petition the
court for lead plaintiff status. Your ability to share in any
recovery does not require that you serve as lead plaintiff. You may
choose to be an absent class member.
If you suffered a loss during the class period and wish to
obtain additional information, please contact Joseph Klein, Esq. by
telephone at 212-616-4899 or visit
http://www.kleinstocklaw.com/pslra-sa/neurotrope-inc?wire=2.
Joseph Klein, Esq. is an experienced attorney and has also
practiced as a Certified Public Accountant. Mr. Klein represents
investors and participates in securities litigations involving
financial fraud throughout the nation. Attorney advertising. Prior
results do not guarantee similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170606006276/en/
The Klein Law FirmJoseph Klein, Esq.Telephone: 212-616-4899Fax:
347-558-9665www.kleinstocklaw.com
NextTrip (NASDAQ:NTRP)
Historical Stock Chart
From Aug 2024 to Sep 2024
NextTrip (NASDAQ:NTRP)
Historical Stock Chart
From Sep 2023 to Sep 2024